CardioBrief: New Analyses Show PCSK9 Inhibitors Are Bad Buy

(MedPage Today) -- ' The most expensive preventive therapies by far in the history of cardiovascular medicine '
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news